Recombinant human LAV-BPIFB4

1. Recombinant human LAV-BPIFB4 increases CD47 in mice.

   “rhLAV-BPIFB4 administration in vivo increased CD47 on murine platelets and reduced, ex vivo, LPS-induced monocyte activation”

   Animalsplatelets

   The LAV-BPIFB4-Platelet-CD47 Axis: A Novel Mechanism Associated With Immune Resilience in Longevity

   Aging cell·25 Jun 2026

More on CD47